A share price of Revelation Biosciences Inc [REVB] is currently trading at $2.74, up 12.76%. An important factor to consider is whether the stock is rising or falling in short-term value. The REVB shares have gain 11.84% over the last week, with a monthly amount drifted -33.50%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 25, March 2024, REVB Begins Trials with Good Cash on Hand. In a post published today on Yahoo Finance, By Brad Sorensen, CFA.
From an analyst’s perspective:
Revelation Biosciences Inc experienced fluctuations in its stock price throughout the past year between $2.22 and $49.80. Revelation Biosciences Inc [NASDAQ: REVB] shares were valued at $2.74 at the most recent close of the market.
Analyzing the REVB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at 0.63, Equity is 0.83 and Total Capital is -1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.44 points at the first support level, and at 2.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.00, and for the 2nd resistance point, it is at 3.26.
Revelation Biosciences Inc [REVB] reported earnings per share of -$8.33 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$13.77/share, meaning a difference of $5.44 and a surprise factor of 39.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$12.6 per share as compared to estimates of -$9 per share, a difference of -$3.6 representing a surprise of -40.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Revelation Biosciences Inc [NASDAQ:REVB] is 2.17. On the other hand, the Quick Ratio is 2.17, and the Cash Ratio is 2.15.
Transactions by insiders
Recent insider trading involved TIDMARSH GEORGE F, Director, that happened on Dec 08 ’23 when 27771.0 shares were sold. Director, TIDMARSH GEORGE F completed a deal on Oct 16 ’23 to sell 10957.0 shares. Meanwhile, Director TIDMARSH GEORGE F sold 1845.0 shares on Oct 16 ’23.
